Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
15.26% $2.19
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 7.98 mill |
EPS: | -1.700 |
P/E: | -1.290 |
Earnings Date: | Feb 09, 2024 |
SharesOutstanding: | 3.65 mill |
Avg Daily Volume: | 0.108 mill |
RATING 2024-03-28 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Neutral | |
P/E: | Neutral | |
Price To Book: | Neutral |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/21 | 3/21 | 1/22 | 3/22 | 1/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
Asset | n/a | n/a | n/a | n/a | n/a | n/a |
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -1.290 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.03x |
Company: PE -1.290 | industry: PE 47.78 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.915 (-58.21%) $-1.275 |
Date: 2024-03-29 |
Expected Trading Range (DAY) |
---|
$ 1.928 - 2.45 ( +/- 11.96%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-12-31 | Harton Lynn | Buy | 0 | |
2004-12-31 | Henriques Adolfo | Buy | 0 | Common Stock |
2004-12-31 | Henriques Adolfo | Buy | 0 | Common Stock |
2004-12-31 | Moore Jackson W | Buy | 0 | |
2004-12-31 | Poynter Lou Ann | Sell | 0 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 77 transactions |
Buy: 1 159 266 | Sell: 963 935 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $2.19 (15.26% ) |
Volume | 0.147 mill |
Avg. Vol. | 0.108 mill |
% of Avg. Vol | 135.51 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.